Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Our Management

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

Board OF DIRECTORS

Joel Thickins

Joel Thickins

Chairman
Joel Thickins

Joel Thickins

Chairman

Joel is a Partner at TPG Capital and leads the firm’s investment program in the ANZ region as Head of Australia and New Zealand. Joel also currently sits on the Board of Inghams Group Limited and has served on the Boards of Accolade Wines, Gerard Lighting, Blue Star Print Group and Centric Wealth.

Dr. Fred Cohen

Dr. Fred Cohen

Board Member
Dr. Fred Cohen

Dr. Fred Cohen

Board Member

Fred Cohen is a Senior Advisor to TPG and was a Partner and co-founder of TPG Biotechnology. Fred has served on the Board of several biotech and pharmaceutical organizations including Biocryst (BCRX), CareDx (CDNA), […] and is a co-founder of Sweetwater Spectrum, a non-profit autism support organization.

 Vinnie Wong

Vinnie Wong

Board Member
 Vinnie Wong

Vinnie Wong

Board Member

Vincent Wong is with TPG Capital and is based in Melbourne, where he works in TPG’s Australian team. Prior to joining TPG in 2011, Vincent served in the Investment Banking Department at Goldman, Sachs & Co. Vincent graduated from The University of Melbourne with BCommerce and BLaws (Honors).

 Lydia Cai

Lydia Cai

Board Member
 Lydia Cai

Lydia Cai

Board Member

Lydia Cai is a Principal at TPG Capital Asia based in Beijing and leads TPG’s healthcare investments in the Greater China area. Prior to joining TPG in 2011, Lydia was an Associate at HAO Capital, a China-focused early stage private equity fund focusing on growth-stage healthcare investments.

Fiona Pak Poy

Fiona Pak Poy

Board Member
Fiona Pak Poy

Fiona Pak Poy

Board Member

Fiona currently serves as a non-executive director for Novotech, Isentia, Tyro Payments and the Sydney School of Entrepreneurship. She has also served on MYOB, PageUp People, the Securities Industry Research Centre of South-East Asia and the federal government board of Innovation Australia.

John Moller

John Moller

CEO
John Moller

John Moller

CEO

John joined Novotech in January 2014 to lead the development of Novotech’s Asia operations. Prior to Novotech John was Managing Director of IVF Australia and Queensland Fertility Group and sat on the Board of the parent company Virtus Health. John is a medical doctor by training.

Brad Campbell

Brad Campbell

CFO and Company Secretary
Brad Campbell

Brad Campbell

CFO and Company Secretary

With a career spanning senior financial positions with a number of multinational organizations, both in North America and Australasia, Brad joined Novotech as CFO in 2006, later becoming a director in 2009.

Veronica Holloway

Veronica Holloway

Director, Legal
Veronica Holloway

Veronica Holloway

Director, Legal

Veronica joined Novotech in May 2014 to formalise the legal function at Novotech. Prior to Novotech, Veronica held roles as Senior Legal Counsel at EY, Senior Solicitor at Clayton Utz and General Counsel (on secondment) at Novartis Pharmaceuticals Australia Pty Limited. Veronica holds a BA/LLB/LLM.

Executive Management

John Moller

John Moller

CEO
John Moller

John Moller

CEO

John joined Novotech in January 2014 to lead the development of Novotech’s Asia operations. Prior to Novotech John was Managing Director of IVF Australia and Queensland Fertility Group and sat on the Board of the parent company Virtus Health. John is a medical doctor by training.

Brad Campbell

Brad Campbell

CFO and Company Secretary
Brad Campbell

Brad Campbell

CFO and Company Secretary

With a career spanning senior financial positions with a number of multinational organizations, both in North America and Australasia, Brad joined Novotech as CFO in 2006, later becoming a director in 2009.

Yooni Kim

Yooni Kim

Executive Director, Asia Operations
Yooni Kim

Yooni Kim

Executive Director, Asia Operations

Dr. Kim is responsible for overseeing Novotech’s operations and project delivery within the Asia region. Prior to joining Novotech, Dr. Kim worked at PRA Health Sciences as Director of Operations for North Asia. She received doctorate degree of medicine from Seoul National University.

Daniela Caiazza

Daniela Caiazza

Director Clinical Operations ANZ
Daniela Caiazza

Daniela Caiazza

Director Clinical Operations ANZ

Daniela joined Novotech in 2009. She is responsible for the strategic planning and management of the clinical operations team to ensure project deliverables. Previously working with Pfizer Pharmaceuticals, she has a strong academic research background in cardiovascular drug development, holding PhD in Chemistry.

Andries Claassen

Andries Claassen

Director, Biometrics
Andries Claassen

Andries Claassen

Director, Biometrics

Andries joined Novotech in September 2008 and has lead Biometrics operations since January 2016. Andries has 15 years’ experience in Clinical Research from previous roles at Quintiles and Elli Lilly. Andries has a track record of meeting all study milestones.

Radha Jha

Radha Jha

Director, Medical Services
Radha Jha

Radha Jha

Director, Medical Services

Radha joined Novotech in April 2007 and held a number of senior project management positions. Radha leads Medical Services at Novotech, driving the company's business strategy in medical monitoring, medical writing, pharmacovigilance and central laboratory.

Kim Wong

Kim Wong

Director, Quality Assurance
Kim Wong

Kim Wong

Director, Quality Assurance

Kim joined Novotech in 2002 and is responsible for overseeing Novotech’s Quality Management System. She has over 19 years experience in clinical research across a wide range of therapeutic and functional areas. Kim has a Bachelor’s degree in Medical Science.

Angela Edwardson

Director, Human Resources

Angela Edwardson

Director, Human Resources

Angela joined Novotech in November 2015 and is responsible for Novotech's Human Resources operations including strategy, organisational development, remuneration & reward and workplace health and safety. Angela is passionate about delivering Novotech's vision of being the leading CRO in the Asia Pacific region.

 Stuart Hall

Stuart Hall

Director, Project Management
 Stuart Hall

Stuart Hall

Director, Project Management

Stuart joined Novotech in 2009 and has lead Novotech’s Project Management team since 2010. Stuart is responsible for project delivery across the Asia Pacific region. Stuart has over 25 years experience in clinical research across all study phases and a wide range of therapeutic areas, and holds a Bachelor’s Degree in Science.

Barry Murphy

Barry Murphy

Director, Business Development
Barry Murphy

Barry Murphy

Director, Business Development

Barry joined in July 2014 to lead the growth of Novotech’s Business Development team. Barry started his career as a pharmacist having graduated from Trinity College Dublin. He began his clinical research career with ICON and worked in both Dublin and Sydney.

Ian Hayes

Ian Hayes

Director, Information Technology
Ian Hayes

Ian Hayes

Director, Information Technology

Ian currently leads the IT department at Novotech, after joining in 2004 as an IT consultant from a background of both management and technical experience consulting to a broad range of industries over a 20 year career.

Veronica Holloway

Veronica Holloway

Director, Legal
Veronica Holloway

Veronica Holloway

Director, Legal

Veronica joined Novotech in May 2014 to formalise the legal function at Novotech. Prior to Novotech, Veronica held roles as Senior Legal Counsel at EY, Senior Solicitor at Clayton Utz and General Counsel (on secondment) at Novartis Pharmaceuticals Australia Pty Limited. Veronica holds a BA/LLB/LLM.

Gabrielle Mckee

Gabrielle Mckee

Director Early Phase Clinical Operations
Gabrielle Mckee

Gabrielle Mckee

Director Early Phase Clinical Operations

With over 25 years’ experience in managing clinical teams and projects at international CROs and local Biotech companies, pharmacovigilance roles in the pharmaceutical industry, and support to development of Biometrics function.

Kristyn Munro

Kristyn Munro

Director, Business Development Operations
Kristyn Munro

Kristyn Munro

Director, Business Development Operations

Kristyn leads Novotech’s Business Development Operations teams, encompassing both Client Operations and Proposals, Budgets and Contracts.  Kristyn has enjoyed a career in clinical development for over twenty years, having worked for Bristol-Myers- Squibb, Astra-Zeneca and Amgen, prior to joining Novotech in 2009. 

Valentin Moingeon, Pharm.D, CFA

Valentin Moingeon

Pharm.D, CFA
Director, Marketing and Analytics
Valentin Moingeon, Pharm.D, CFA

Valentin Moingeon

Pharm.D, CFA
Director, Marketing and Analytics

Valentin joined the company in 2016 to lead the Marketing and Analytics team, and has over 10 years of experience in the Life Science sector. Prior to joining Novotech, Valentin held several roles in the Pharmaceutical Industry in Business Development in Europe and Asia. Valentin is a Doctor of Pharmacy and a CFA Charterholder. …